OTCQX: EMHTF) has received its initial cultivation license from Health Canada for its new organic cannabis growing facility in Metro Vancouver, BC. Tailor-made for Emerald to produce high-quality organic...
Emerald Health Therapeutics Receives Cultivation License for New-Build Organic Cannabis Operation in Britis
OTCQX: EMHTF) has received its initial cultivation license from Health Canada for its new organic cannabis growing facility in Metro Vancouver, BC. Tailor-made for Emerald to produce high-quality organic...
Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulatio
OTCQX: EMHTF) is pleased that today the Government of Canada released the final regulatory framework for ingestibles and edibles. “The clarity of the final regulatory framework provides is important for...
Emerald Health Therapeutics to Present At Oppenheimer Consumer Growth and E-Commerce Conference
OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, will participate in the Oppenheimer 19th Annual Consumer Growth and E-Commerce Conference on June 18, 2019...
Emerald Health Therapeutics Contracts for 1,200 Acres of Canadian Hemp Harvest, Reports Significant Progres
OTCQX: EMHTF) reports that is has expanded its agreement to purchase harvested hemp flower and leaf, or hemp chaff, from Emerald Health Hemp Inc. (“EHH”) from 1,000 to 1,200 acres for 2019. EHH is a wholly...
Emerald Health Therapeutics to Participate at Investment and Industry Conferences in June
VANCOUVER, British Columbia, June 03, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in multiple upcoming investment and.
Emerald Health Therapeutics Reports First Quarter 2019 Financial Results; Demonstrates Continued Growth in
VANCOUVER, British Columbia, May 31, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended.
NEW YORK, NY / ACCESSWIRE / May 31, 2019 / Emerald Health Therapeutics, Inc. (TSXVENTURE: EMHTF ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 31, 2019...
Emerald Completes Issuance of Shares in Lieu of Cash Due for Verdélite Acquisition
OTCQX: EMHTF) today announced that the vendors (the "Vendors") of Verdélite Sciences, Inc. and Verdélite Property Holdings, Inc. (collectively, "Verdélite") have received 2,129,707 shares of Emerald (the...
Emerald Health Therapeutics to Lead International Affairs Council on CBD and Hemp’s Dialog with FDA on CBD
OTCQX: EMHTF) has been appointed by the American Trade Association for Cannabis and Hemp (ATACH) to lead its International Affairs Council on CBD and Hemp in ATACH’s engagement with the US Food & Drug...
VICTORIA, British Columbia, May 22, 2019 -- Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) has appointed Sean Rathbone as Chief Operating Officer. Mr..
We’re different. We were formed by a team that has dedicated their working lives to the health sciences, helping people overcome everyday medical conditions to live better lives. We're focused on harnessing the complexity of the endocannabinoid system and the cannabis plant to create better-controlled outcomes for everyone.
Through scientific research, we want to create a world where there is greater knowledge and understanding of the health and wellness benefits of marijuana, and where people can make educated decisions without safety concerns or fear of stigma.
Health and wellness options come from either the traditional pharmaceutical world or the natural health world. Through the science of the endocannabinoid system and the cannabis plant we offer the best of both worlds – controlled, predictable, effective outcomes from a natural, plant-based source.
We serve everyday people – men and women with normal lives and normal jobs. Whether they are using our medical or adult-use marijuana products, they're using them for a purpose; they are looking for an outcome that will improve their quality of life.
At Emerald Health, extraordinary, cutting edge cannabis science meets human understanding. The outcome is the innovation and intellectual property needed to precisely deliver controlled, specific, predictable outcomes for the people we help.
Emerald uses state-of-the-art growing processes to grow our medical cannabis, such as high-intensity discharge (HID) lights and a steam-sterilized growing medium. Once marijuana growing is complete, every batch is tested at an independent third-party lab to ensure it meets the required standards.
Emerald Health Therapeutics cultivates medical cannabis using proven and standardized marijuana growing methods while applying their research capabilities to discover potential medicinal benefits of cannabis for the future.
Closed now